A cost-utility analysis of Glecaprevir/Pibrentasvir versus Sofosbuvir/Daclatasvir and Sofosbuvir/Velpatasvir for treatment of hepatitis C in Iran. [PDF]
Jafari M +6 more
europepmc +1 more source
Lysyl oxidase-like 2 as a predictor of hepatocellular carcinoma in patients with hepatitis C virus after sustained virological response. [PDF]
Chida T +12 more
europepmc +1 more source
Impact of viral eradication by direct-acting antivirals on clinical outcomes after curative treatment for hepatitis C virus-associated hepatocellular carcinoma. [PDF]
Nagaoki Y +12 more
europepmc +1 more source
The Prevalence of Potential Drug-Drug-Gene Interactions: A Descriptive Study Using Swiss Claims Data. [PDF]
Wittwer NL +6 more
europepmc +1 more source
The Rise of Fine-Tuned CAR-Based Therapies Against Acute Myeloid Leukemia. [PDF]
Segura Tudela A +9 more
europepmc +1 more source
Risk for Recurrence After Liver Resection in Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma Detected After Sustained Virological Response by Direct-Acting Antivirals: A Retrospective Multicenter Study. [PDF]
Tanaka S +12 more
europepmc +1 more source
The Effects of Pangenotypic Direct-Acting Antiviral Therapy on Lipid Profiles and Insulin Resistance in Chronic Hepatitis C Patients. [PDF]
Ko MY, Hsu YC, Yen HH, Huang SP, Su PY.
europepmc +1 more source
Geometric Deep learning Prioritization and Validation of Cannabis Phytochemicals as Anti-HCV Non-nucleoside Direct-acting Inhibitors. [PDF]
Charles S, Edgar MP.
europepmc +1 more source

